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A B S T R A C T
Actin dynamics regulate cell behaviour in response to physiological signals. Here we demonstrate a novel role for
nuclear actin in inhibiting cell proliferation and migration. We demonstrate that physiological signals that
elevate cAMP, which is anti-mitogenic in vascular smooth muscle cells, increases nuclear actin monomer levels.
Expression of a nuclear-targeted polymerisation-defective actin mutant (NLS-ActinR62D) inhibited proliferation
and migration. Preventing nuclear actin monomer accumulation by enhancing its nuclear export or poly-
merisation reversed the anti-mitogenic and anti-migratory effects of cAMP. Transcriptomic analysis identified
repression of proliferation and migration associated genes regulated by serum response factor (SRF) and TEA
Domain (TEAD) transcription factors. Accordingly, NLS-ActinR62D inhibited SRF and TEAD activity and target
gene expression, and these effects were reversed by constitutively-active mutants of the TEAD and SRF co-factors
YAP, TAZ and MKL1. In summary, intranuclear actin inhibits proliferation and migration by inhibiting YAP-
TEAD and MKL-SRF activity. This mechanism explains the anti-mitogenic and anti-migratory properties of
physiological signals that elevate cAMP.
Summary: McNeill et al show that increased levels of intranuclear actin monomer inhibit cell proliferation and
migration by inhibiting MKL1-SRF and YAP/TAZ-TEAD-dependent gene expression. This mechanism mediates
the anti-mitogenic and anti-migratory effects of physiological signals that elevate cyclic-AMP.
1. Introduction
Most cells respond to a complex multitude of mechanical and bio-
chemical, micro-environmental signals by reorganising their actin cy-
toskeleton. This plays a central role in determining appropriate cellular
responses including proliferation and migration. For example, cell ad-
hesion to specific extracellular matrix (ECM) proteins influences cell
proliferation via integrin dependent changes in cell shape and actin
cytoskeleton organisation [1,6] Generation of tensile forces in F-actin
stress fibres in response to changes in ECM stiffness, cell spreading, or
cell-to-cell contact are also essential for cell-cycle progression in ad-
hesion-dependent cell types [13,47]. Likewise, actin cytoskeleton
polymerisation and formation of tensed F-actin stress fibres are essen-
tial for cell cycle progression in response to mitogen stimulation [21].
Pharmacological disruption of actin polymerisation with specific actin
binding drugs (e.g. cytochalasin-D or latrunculin-B) or by imposing
constraints on cell spreading blocks the ability of cells to respond to
mitogens and proliferate [4,29,30]. Importantly, reduced actin
polymerisation and stress fibre formation has also been implicated in
the anti-mitogenic actions of physiological signals, including activators
of Gs coupled GPCRs that elevate intracellular levels of 3′,5′-cyclic
adenosine monophosphate (cAMP) [5,24,35,36,53]. In some cell types,
including vascular smooth muscle cells (VSMC), elevated cAMP po-
tently blocks cell proliferation and migration [26–28,55]. In these cells,
the anti-mitogenic and anti-migratory properties of cAMP are depen-
dent on inhibition of RhoGTPase activity, including RhoA and Rac1,
resulting in impaired actin polymerisation [5]. For example, expression
of constitutively active mutants of RhoA or Rac1 prevents cAMP in-
duced disruption of actin stress fibres and reverses growth arrest [5].
These observations suggest that the actin cytoskeleton acts as an im-
portant point of convergence of multiple growth regulatory pathways
and signals from the local microenvironment to control proliferation
and migration.
Several mechanisms have been proposed to explain how actin cy-
toskeleton reorganisation controls cell fate. For example, cell cycle ar-
rest in response to cytoskeleton disruption is associated with failure to
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induce sustained MAPK activity in response to mitogen stimulation
[49], which prevents induction of Cyclin D and downregulation the
cyclin-dependent kinase inhibitor p27KIP1 [25]. Together this prevents
cyclin dependent kinases activation and G1-restriction point transit.
However, the anti-mitogenic effects of signals that disrupt the actin
cytoskeleton can be dissociated from their effects on MAPK activity and
cyclin expression [7,25]. For example, disruption of actin polymerisa-
tion in response to cAMP elevating stimuli inhibits S phase entry in cells
in which MEK activity has been pharmacologically inhibited [7], thus,
implicating additional early regulatory mechanisms.
Fig. 1. cAMP signalling increases levels of intranuclear actin
VSMCs were stimulated with Latrunculin-B (0.25 μg/ml) or Jasplakinolide (0.5 μM) for 2 h and nuclear actin monomer quantified by DNAse1 staining (A). VSMC
were stimulated forskolin (25 μM), Db-cAMP (200 μM), BAY65-60583 (BAY; 1 μg/ml) or Cicaprost (Cica; 2 μM) for 2 h and stained for actin monomer with DNAse1
(B) and intranuclear actin levels quantified (C). Cytoplasmic mask represents a black and white image generated from the DAPI nuclear signal and used to mask the
cytoplasmic DNAse1 signal. Scale bar indicates 50 μm. Cells were stimulated with BAY60-6583 (1 μg/ml) for indicated times and intranuclear actin levels quantified
(D). VSMCs and HUVECs were stimulated with forskolin (25 μM) for 2 h and intranuclear actin levels quantified (E). Data is mean ± standard error. One-way
ANOVA with Student Newman Keuls post-test. * indicates p < 0.05, ** indicates p < 0.01 and *** indicates p < 0.001.
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Most research on actin has focussed on understanding its function as
a component of the cytoplasmic cytoskeleton. However, several reports
provide evidence that actin is present within the nucleus [8,31,61],
where it plays a significant role in several nuclear processes, including
transcription and chromatin remodelling. Early studies detected actin
or actin-like proteins in the nuclei of various cells [11,31,38,44].
However, the evidence was not widely accepted and believed to be a
contamination artefact. Furthermore, the mere presence of actin in
nuclei was not considered strong evidence that it has a role in nuclear
functions. Only recently has the presence of actin within the nucleus
become widely accepted and recognised to play important roles in
nuclear processes, including RNA polymerase activity, gene transcrip-
tion, heterochromatin remodelling and regulation of cell fate decisions,
including apoptosis and differentiation [32].
Levels of nuclear actin are actively controlled and highly regulated.
Translocation of actin, which lacks an intrinsic nuclear localisation
signal, into the nucleus depends on interaction with cofilin. These ac-
tin:cofilin complexes are transported into the nucleus via interaction
with the specific importer protein Importin-9 (IPO9). Although β-actin
contains two nuclear export sequences, actin nuclear export is depen-
dent on interaction with exportin-6 (XPO6) in association with Profilin.
Actin in the nucleus can rapidly transition between monomeric and
polymeric forms. Actin polymerisation within the nucleus can be pro-
moted by members of the diaphanous-related formins such as mDIA1
and mDIA2 and members of the RhoGTPases, such as RhoA, which have
both been detected within the nucleus [32,58]. This high degree of
regulation is consistent with the important functional roles for intra-
nuclear actin [32,50,58].
Although the presence of actin within the nucleus and its im-
portance in chromatin and transcriptional regulation is now widely
accepted, relatively little is known about the physiological signals that
modulate nuclear actin levels and the importance of this in the reg-
ulation of cell behaviour. Based on observations from our laboratory
that the anti-mitogenic and anti-migratory properties of elevated cAMP
are dependent remodelling of the actin cytoskeleton [5,24,35,36,53],
we hypothesised that cAMP elevating stimuli would modulate levels of
intra-nuclear actin and that this regulation of intranuclear actin level
might underlie the anti-mitogenic and anti-migratory effects of cAMP..
2. Results
2.1. Cyclic-AMP elevating stimuli increase levels of nuclear actin monomer
We first tested if physiological anti-mitogenic signals modulate le-
vels of nuclear actin monomer. We studied signals that elevate levels of
the second messenger cAMP, since these have anti-mitogenic effects in
several different cell types, including vascular smooth muscle cells
[26,34,48], and have been linked to actin cytoskeleton remodelling
[5,24]. We exploited the well characterised high affinity of DNAse1 for
actin monomer over actin polymer [42] to detect and quantify intra-
nuclear actin monomer levels, as previously described [37,57]. To va-
lidate this technique, we treated cells with latrunculin-b, to induce actin
depolymerisation, or jasplakinolide, to induce actin polymerisation.
Quantification of confocal z-stack images of DNAse1-Alexa Fluor-594
stained cells revealed that latrunculin-B significantly increased intra-
nuclear staining of actin monomer and jasplakinolide significantly de-
creased nuclear staining of actin-monomer, consistent with specific
detection of actin monomer (Fig. 1A). Furthermore, consistent with
previous reports that cAMP induces depolymerisation of the cyto-
plasmic actin cytoskeleton in VSMCs [24], we observed an increase in
cytoplasmic DNAse1 staining intensity in cells treated with the adeny-
late cyclase agonist, forskolin; the cAMP-analogue, dibutyryl-cAMP; the
adenosine A2B-receptor agonist, BAY60-6583; or the prostacyclin, mi-
metic, Cicaprost (Fig. 1B). Importantly, all these stimuli also induced a
significant increase in nuclear actin monomer levels (Fig. 1B and C).
Similar increases in nuclear actin monomer levels were detected in
human VSMCs in response to forskolin stimulation (Supplement Fig. 1).
Time course analysis of BAY60-6583 stimulated cells demonstrated that
nuclear actin monomer levels were significantly increased after one
hour and were maximal after 4 h (Fig. 1D). By contrast, forskolin sti-
mulation did not increase nuclear actin monomer levels in endothelial
cells (ECs; Fig. 1E), where elevated cAMP signalling is not associated
with growth arrest [53]. Taken together, these data demonstrate that
physiological stimuli that elevate intracellular cAMP increase nuclear
actin monomer levels in VSMCs but not ECs and that this corresponds
with the previously described anti-mitogenic properties of cAMP in
these two cell types [53].
2.2. Intranuclear actin monomer inhibits cell proliferation and migration in
VSMCs
We next asked whether nuclear actin monomer not only correlates
with but also plays a role in inhibiting VSMC proliferation and cell
migration. We employed multiple approaches to specifically modulate
nuclear actin monomer levels, including adenovirus mediated over
expression of polymerisation defective mutant (R62D) of actin tagged
with a nuclear localisation signal (Ad:NLS-ActinR62D); overexpression of
the actin importer, importin 9 (Ad:IPO9); over expression of the actin
exporter, XPO6 (Ad:XPO6); siRNA-mediated silencing of XPO6
(siXPO6); and over expression of a constitutively active mutant of
mDIA1 (Ad:mDIA1-CT), which accumulates in the nucleus due to a
cryptic nuclear localization sequence (NLS) [2]. Expression of NLS-
ActinR62D (Ad:NLS-ActinR62D) resulted in specific nuclear expression of
FLAG-tagged ActinR62D (Supplement Fig. 2). It is important to note that
infection with Ad:NLS-ActinR62D did not result in a detectable differ-
ence in the total cellular levels of β-actin, even though FLAG-tagged
NLS-ActinR62D was clearly detectable (Supplement Fig. 2B), indicating
that expression from this vector is sufficient to specifically increase
nuclear actin monomer levels without significantly affecting the total
cellular pool of β-actin However, DNAse1-Alexa Fluor-594 staining
detected a significant increase in actin monomer levels in cells infected
with Ad:NLS-ActinR62D (Fig. 2A). Infection of cells with Ad:IPO9 also
significantly increased nuclear actin monomer levels (Fig. 2A), while
infection with Ad:XPO6 or Ad:mDIA-CT significantly decrease basal
nuclear actin monomer levels (Fig. 2A). Overexpression of mDIA-CT in
cells expressing nuclear localised Lifeact-EGFP resulted in formation of
highly organised nuclear actin network, suggesting that mDIA-CT re-
duced nuclear actin monomer levels by promoting nuclear actin poly-
merisation (Supplement Fig. 3).
Expression of NLS-ActinR62D significantly inhibited proliferation of
VSMCs (Fig. 2B and Supplement Fig. 3A) but not coronary artery en-
dothelial cells (HCAECs) (Fig. 2B). Expression of NLS-ActinR62D also
significantly inhibited migration of VSMCs (Fig. 2C and Supplement
Fig. 4B) but not HCAECs (Fig. 2D) in real-time scratch wound assays. To
test the role of nuclear actin monomer in the regulation of proliferation
and migration further, we increased nuclear actin levels by over ex-
pressing IPO9 and silencing XPO6. Infection of VSMCs with Ad:IPO9
significantly inhibited proliferation of VSMCs (Fig. 2E) and significantly
inhibited their migration (Fig. 2F). Furthermore, transfection of cells
with siRNA targeting XPO6 reduced XPO6 protein levels (Fig. 2G), in-
creased levels of nuclear actin monomer (Fig. 2H), and significantly
inhibited cell proliferation (Fig. 2I) and migration (Fig. 2J). Taken to-
gether, these data demonstrate that increased nuclear actin inhibits
VSMC proliferation and migration.
2.3. Increased intranuclear actin monomer mediates that anti-mitogenic
and anti-migratory effects of cAMP in VMSCs
We went on to investigate to what extent the anti-mitogenic and
anti-migratory effects of cAMP in VSMCs are dependent on increased
levels of nuclear actin monomer. We used adenoviral mediated ex-
pression of XPO6 (Ad:XPO6) or mDIAF1F2+C (Ad:mDIA-CT) to reverse
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cAMP-mediated increases in nuclear actin monomer levels. Foskolin
treatment of cells infected with a control adenovirus significantly in-
creased nuclear actin monomer. However, infection with Ad:XPO6 or
Ad:mDIA-CT significantly reduced basal nuclear actin monomer levels
(Fig. 3A) and, importantly, completely reversed the forskolin induced
increase in nuclear actin monomer levels, detected by DNAse1-Alexa
Fluor-594 staining. Forskolin treatment of cells infected with a control
adenovirus significantly inhibited cell proliferation (Fig. 3B and D),
consistent with our previous observations [53]. Infection with
Ad:XPO6, however, significantly increased basal proliferation rates and
rescued proliferation after forskolin treatment to levels that were not
significantly different from untreated Ad:Control infected cells
(Fig. 3B). Ad:XPO6 infection also significantly increased basal migra-
tion rates and completely prevented the inhibitory effects of forskolin
on migration (Fig. 3C). Overexpression of XPO6 also reversed the anti-
mitogenic (Supplement Fig. 5A and B) and anti-migratory effects
Fig. 2. Intranuclear actin inhibits VSMC but not EC proliferation and migration.
VSMCs were infected with either Ad:Control, Ad:NLS-ActinR62D or Ad:IPO9, as indicated. Intranuclear actin levels were quantified by DNAse1 staining (A). VSMCs
and HCAECs were infected with Ad:Control or Ad:NLS-ActinR62D. Cell proliferation was quantified by incorporation of Edu 24 h post infection (B). VSMC (C) and
HCAEC (D) migration was quantified by Incucyte migration assay 24 h post infection. VSMC were infected with either Ad:Control or Ad:IPO9 and incorporation of
Edu (E) and migration (F) quantified. VSMCs were transfected with siRNA targeting XPO6 (siXPO6). XPO6 and GAPDH protein levels were quantified 24 h post
transfection by Western blotting (G). Intranuclear actin levels were quantified by co-transfection with GFP-Actin (H). Cell proliferation was quantified by in-
corporation of Edu (I) and cell migration quantified by Incucyte migration assay (J).
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(Supplement Fig. 5C and D) of the adenosine A2B-receptor agonist
BAY60-6582. Infection with Ad:mDIA-CT, also completely reversed
forskolin mediated cell-cycle arrest (Fig. 3D), without affecting basal
proliferation rates. Infection with Ad:mDIA-CT significantly increase
basal migration rates (Fig. 3E). Although forskolin treatment resulted in
a small but significant inhibition of migration, migration rates in these
cells was still significantly higher than that in untreated Ad:Control
infected cells (Fig. 3E). Taken together, these data demonstrate that
cAMP-elevating stimuli increase levels of intranuclear actin monomer
and that this is essential for the anti-mitogenic and anti-migratory
properties of cAMP in VSMCs.
2.4. Transcriptomic analysis reveals that intranuclear actin and elevated
cAMP repress SRF and TEAD target genes associated with proliferation and
migration
We performed RNA-seq to compare the transcriptomic profile of
cells treated with forskolin or expressing NLS-ActinR62D to gain an in-
sight into the mechanisms underlying the anti-mitogenic effects of nu-
clear actin (see supplementary data file S1). Forskolin treatment sig-
nificantly increased the expression of 976 genes by> 1.5 fold and
decrease the expression of 1209 genes by> 1.5 fold compared to
controls. Expression of NLS-ActinR62D increased the expression of 2585
Fig. 3. Increased intranuclear actin mediates the anti-proliferative and anti-migratory effects of cAMP in VSMCs
VSMC were infected with either Ad:Control, Ad:XPO6 or Ad:mDIACT, as indicated. Cells were stimulated with 25 μM forskolin for 2 h and levels of intranuclear actin
quantified by DNAse1 staining (A). VSMCs were infected with Ad:XPO6 (B and C) or Ad:mDIACT (D and E). Cell proliferation was quantified by incorporation of Edu
(B and D). Cell migration was quantified by real time migration assay (C and E).
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genes by> 1.5 fold and decrease the expression of 2425 genes by>1.5
fold compared to Ad:Control (Fig. 4A and B). Of these genes, 390 were
upregulated by both forskolin and NLS-ActinR62D and 537 were
downregulated by forskolin and NLS-ActinR62D. Gene ontology (GO)
enrichment analysis of genes downregulated>1.5 fold by forskolin
identified significant enrichment of genes associated with positive
regulation of smooth muscle cell proliferation (GO:0048661) and cell
migration (GO:0016477) (Fig. 4C). Likewise, GO enrichment analysis of
genes downregulated>1.5 fold by NLS-ActinR62D also identified sig-
nificant enrichment of genes associated with positive regulation of cell
migration (GO:0016477), DNA replication (GO:0006260), and positive
regulation of cell proliferation (GO:0008284) (Fig. 4D). Importantly,
the 537 genes that were down regulated by forskolin or NLS-ActinR62D
were also enriched in genes associated with also positive regulation of
cell proliferation (GO:0008284) and cell migration (GO:0030334)
(Fig. 4E). Taken together, these data indicate that cAMP and intra-
nuclear actin monomer regulate a common set of genes associated with
proliferation and cell migration.
We performed gene set enrichment analysis (GSEA) to identify up-
stream regulatory transcription factors potentially involved in med-
iating gene expression changes in response to cAMP or nuclear actin
monomer. We initially searched for enrichment of Molecular Signatures
Database (MSigDB; Broad Institute) transcription factor target gene sets
in ranked lists of genes derived from the NLS-ActinR62D and forskolin
datasets. As expected, GSEA of the forskolin dataset identified enrich-
ment of CREB and ATF3 target genes amongst the genes positively
regulated by forskolin, consistent with well characterised activation of
these transcription factors by cAMP (Fig. 5A). However, neither CREB
nor ATF3 were enriched in the NLS-ActinR62D gene set, implying se-
lective regulation of these TFs by cAMP. Importantly, we identified
Fig. 4. Transcriptomic analysis of nuclear actin and cAMP regulated genes
Venn diagrams of genes upregulated (A) and down regulated (B) in response to a 6-h stimulation with 25 μM forskolin (black circles) or expression of NLS-ActinR62D
(white circles). Gene ontology analysis of genes down regulated> 1.5 fold in response to 6-h forskolin stimulation (C); Genes down regulated> 1.5 fold in response
NLS-ActinR62D (D); or gene down regulated by>1.5 fold by 25 μM forskolin or NLS-ActinR62D (E).
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significant enrichment of SRF and TEAD target genes amongst the genes
negatively regulated by forskolin and NLS-ActinR62D (Fig. 5A), sug-
gesting that SRF and TEAD TFs are inhibited by elevated cAMP and by
nuclear actin. To test this further, we searched for an enrichment of
genes identified by Esnault et al [17] as MKL-SRF signature genes and
genes identified by Zhao et al. [70] as upregulated by over expression
the TEAD co-factor Yes Associated Protein-1 (YAP). This analysis
identified significant enrichment of MKL-SRF signature genes (Fig. 5B)
and enrichment of YAP-induced genes (Fig. 5C) amongst the genes
repressed by forskolin and by NLS-ActinR62D, again indicating selective
down regulation of MKL-SRF and YAP-target genes by cAMP and nu-
clear actin. Finally, we looked for enrichment of genes having an SRF or
TEAD binding sites within 1kbp, 10kbp, 50kbp or 100 kbp of their TSS,
identified by SRF or TEAD4 ChiP respectively (ENCODE database). This
analysis identified significant enrichment of genes with at least one SRF
or TEAD ChIP binding sites within the promoter regions of the NLS-
ActinR62D and the forskolin repressed gene sets (Fig. 5D and E). Finally,
we searched for consensus SRF (Jaspar SRF motif MA0083.1) and TEAD
Fig. 5. Gene Set Enrichment Analysis (GSEA) of intranuclear actin and forskolin regulated genes.
GSEA of broad institute molecular signatures database C3:motif gene sets in NLS-ActinR62D and forskolin regulated genes (A). GSEA of an MKL-SRF gene signature
gene set [17] in NLS-ActinR62D and forskolin regulated genes (B). GSEA of a YAP gene signature gene set [70] in NLS-ActinR62D and forskolin regulated genes (C).
GSEA of genes with a SRF ChIP-seq peak (ENCODE) within 1 kbp, 10 kbp, 50 kbp or 100 kbp of their TSS (D). GSEA of genes with a TEAD4 ChIP-seq peak (ENCODE)
within 1 kbp, 10 kbp, 50 kbp or 100 kbp of their TSS (D). GSEA of genes with a SRF ChIP-seq peak (ENCODE) within 1 kbp, 10 kbp, 50 kbp or 100 kbp of their TSS
(E). Venn diagram showing percentage of genes that have either an SRF element (MA0083.1; MA0083.2;MA0083.3), a TEAD element (MA0090.1; MA0090.2;
MA0808.1; MA0809.1) or both within 1 kbp upstream of the TSS, which are repressed>1.5 fold by NLS-ActinR62D and forskolin (F).
M.C. McNeill, et al. BBA - Molecular Cell Research 1867 (2020) 118691
7
elements (Jaspar TEAD motifs MA0090.1, MA0090.2, MA0808.1,
MA0809.1, MA1121.1) within 10kbp upstream of the TSS of genes co-
ordinately down regulated by forskolin of NLS-ActinR62D. We found that
59.88% of these genes contain at least one SRF and TEAD binding
element; 24.25% of genes contained at least one TEAD element but no
SRF elements and 0.37% of genes contained at least one SRF element
but no TEAD element (Fig. 5F). We did not detect either SRF or TEAD
elements in 15.49% of the genes.
2.5. Intranuclear actin inhibits SRF and TEAD activity and target gene
expression
Since SRF and TEAD TFs were identified by our GSEA and TF
binding element enrichment analysis, we next asked if nuclear actin
monomer inhibited their activity in VSMCs. As a positive control cells
were treated with forskolin, which significantly inhibited SRE- and
TEAD-dependent reporter gene activity (Fig. 6A), consistent with our
previous findings [36,52]. Importantly, expression of NLS-ActinR62D
also significantly inhibited SRE- and TEAD-dependent reporter activity
Fig. 6. Intranuclear actin inhibits SRF and TEAD activity and target gene expression.
VSMCs were stimulated with 25 μM forskolin for 6 h or infected with Ad:NLS-ActinR62D as indicated. SRE-LUC or TEAD-LUC (A, C, E) activity was quantified. Total
RNA was extracted and analysed using qRT-PCR for mRNA levels of SRF and TEAD target genes (B, D, F). Levels of the SRF and TEAD-independent housekeeping
gene 36B4 was used as a control. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.
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(Fig. 6A), without affecting activity of a reporter driven by a minimal
promoter (minP-LUC) lacking SRE or TEAD elements. Forskolin and
NLS-ActinR62D also significantly inhibited steady-state mRNA levels of
SRF- and TEAD-target genes, Ccn1, Ctgf, Pai1, Heyl and Zyxin (Zyx),
without affecting levels of the housekeeping gene 36B4 (Fig. 6B),
consistent with specific inhibition of SRF and TEAD activity by intra-
nuclear actin. To test this further, we prevented nuclear export of actin
by silencing XPO6. This significantly inhibited SRF and TEAD-depen-
dent reporter activity (Fig. 6C) and significantly inhibited mRNA levels
of Ccn1, Ctgf, Pai1, Heyl and Zyxin without affecting the levels of the
housekeeping gene 36B4 (Fig. 6D). Lastly, we increased nuclear actin
levels by over expressing IPO9. This significantly inhibited SRE- and
TEAD-dependent reporter activity, without affecting activity of a
minimal promoter reporter (Fig. 6E) and significantly inhibited ex-
pression of the TEAD and SRF-target genes Ccn1, Ctgf, Pai1, Heyl and
Zyxin. Taken together, these data demonstrate that increased intra-
nuclear actin inhibits SRF and TEAD activity and target gene expres-
sion.
The transcriptional activity of TEAD is dependent on the tran-
scriptional co-factors Yes-Associated Protein (YAP) [62]. In a similar
manner, transcriptional activity of SRF can be regulated by the tran-
scriptional co-factor MKL1 [43]. To better understand the mechanisms
underlying the inhibition of SRF and TEAD we tested if nuclear actin
affected the cellular localisation of YAP and MKL1, respectively. Ex-
pression of NLS-ActinR62D did not significantly affect levels of nuclear
or cytoplasmic YAP and hence the cytoplasmic:nuclear ratio was un-
changed (Supplement Fig. 6A and B). However, stimulation with for-
skolin, which induces loss of cytoplasmic actin stress fibres [53], did
induce a reduction in nuclear YAP and an increase in the cyto-
plasmic:nuclear YAP ratio (Fig. 4C and D), consistent with our previous
data showing that elevated cAMP induces YAP nuclear export [36].
Expression of NLS-ActinR62D completely prevented nuclear localisation
of MKL1 (Fig. 4E and F).
We next asked in intranuclear actin modulated phosphorylation
levels of YAP, since increased YAP phosphorylation is associated with
reduced TEAD activity [67]. Although disruption of actin polymerisa-
tion with latrunculin-B strongly increased global YAP phosphorylation,
detected by reduced electrophoretic mobility on Phostag-acrylamide
gels (Supplement Fig. 7A and B), and phosphorylation on serine-397,
expression of NLS-ActinR62D did not change YAP phosphorylation
globally or specifically on serine-127 or serine-397 (Supplement Fig. 7A
and B). Taken together, these data indicated that intranuclear actin
inhibits SRF by preventing nuclear accumulation of MKL1 but intra-
nuclear actin mediated inhibition of TEAD occurs independently of
changes in nuclear YAP levels or phosphorylation status.
2.6. Increased intranuclear actin mediates the inhibitory effects of cAMP on
SRF and TEAD-dependent gene expression
We previously reported and confirmed here that cAMP signalling
inhibits SRF and TEAD-dependent gene expression in VSMCs and that
this is important in mediating the anti-mitogenic properties of cAMP in
these cells [36,53]. Therefore, we tested if increased nuclear actin un-
derlies these inhibitory effects of cAMP signalling on SRF and TEAD
dependent gene expression. We over expressed of XPO6 or con-
stitutively active nuclear mDIA1 (mDIA:F1F2+C) to reverse the for-
skolin induced increase in nuclear actin monomer and analysed effects
on SRF and TEAD reporter activity and target gene expression. In
control adenovirus infected cells forskolin significantly inhibited SRE-
LUC (Fig. 7A and C) or TEAD-LUC (Fig. 7B and D) reporter activity.
Over expression of XPO6 significantly increased basal activity of SRE-
LUC (Fig. 7A) or TEAD-LUC (Fig. 7B). Importantly, expression XPO6
rescued SRE-LUC and TEAD-LUC activity to levels that were not dif-
ferent from unstimulated Ad:Control infected cells. Moreover, expres-
sion of mDIACT also completely reversed the forskolin-mediated in-
hibition of SRE-LUC (Fig. 7C) and TEAD-LUC (Fig. 7) activity. These
data indicate that cAMP signalling inhibits SRF and TEAD activity, at
least in part by elevating nuclear actin monomer levels. To test this
further we analysed effects on SRF and TEAD-target gene mRNA levels.
Over expression of XPO6 significantly increased basal expression of
Ccn1, Ctgf, Pai1, Heyl and Zyxin and rescued expression after forskolin
treatment to levels not different from unstimulated Ad:Control infected
cells (Fig. 7E). In a similar way, expression of mDIACT completely
prevented the forskolin mediated inhibition of Ccn1, Ctgf, Pai1, Heyl and
Zyxin mRNA levels (Fig. 7F). Taken together, these data demonstrate
that elevated cAMP inhibits SRF and TEAD-dependent gene expression
at least in part by increasing intranuclear actin monomer levels.
2.7. Intranuclear actin mediated inhibition of TEAD activity is independent
of effects on MKL1
Recent studies have reported mutual dependence of MKL-SRF and
YAP-TEAD pathways [19]. Cross talk between MKL and YAP-TEAD
activity has also been reported via formation of an MKL-YAP-TEAD
ternary complex [33]. We therefore used over expression of con-
stitutively active mutants of YAP (YAPS27A), TAZ (TAZ5SA) or MKL1
(MKL1Δ100) to test if inhibition of either TEAD or SRF activity by in-
tranuclear actin was direct or else mediated via crosstalk between these
two pathways. NLS-ActinR62D expression inhibited SRE-LUC activity in
control virus infected cells (Supplement Fig. 8A). Expression of
MKL1Δ100 strongly enhanced the basal SRE-LUC activity and prevented
inhibition by NLS-ActinR62D, consistent with the well characterised
function of MKL1 as an SRF cofactor. Surprisingly, expression of either
YAPS127A or TAZ5SA enhanced basal SRF-LUC activity, although to a
lower level than induced by MKL1Δ100, implying that YAP and TAZ can
enhance SRF activity, possibly via cross talk between YAP/TAZ-TEAD
and SRF. YAPS127A or TAZ5SA also prevented the inhibition of SRF-LUC
activity in response to NLS-ActinR62D (Supplement Fig. 8A). This sug-
gests that repression of SRF activity by intranuclear actin is at least in
part mediated via this crosstalk with the YAP/TAZ-TEAD pathway.
Expression of NLS-ActinR62D also inhibited TEAD-LUC activity (Sup-
plement Fig. 8B). Expression of either YAPS127A or TAZ5SA strongly
enhanced basal activity and reversed the inhibitory effects of NLS-Ac-
tinR62D. Importantly, expression of MKL1Δ100 did not significantly en-
hance basal TEAD-LUC activity or reverse the inhibitory effects of NLS-
ActinR62D, implying that MKL1-SRF signalling does not cross talk with
the YAP/TAZ-TEAD pathway. Taken together, these data suggest that
intranuclear actin mediated inhibition of TEAD activity occurs in-
dependently of effects on MKL-SRF. However, intranuclear actin-
mediated inhibition of SRF involves crosstalk from the YAP/TAZ-TEAD
pathway.
2.8. Active mutants of YAP, TAZ and MKL reverse the inhibitory effects of
intranuclear actin on SRF and TEAD-dependent gene expression,
proliferation and migration
We next tested the importance of TEAD or SRF inhibition by nuclear
actin in the regulation of endogenous gene expression, proliferation and
migration. Expression of YAPS127A significantly reversed the inhibitory
effects of NLS-ActinR62D on Ccn1, Ctgf and Zyxin mRNA levels but not
levels of Pai1 (Fig. 8A). Expression of MKL1Δ100 partially rescued mRNA
levels of Ccn1 and completely rescued levels of Pai1, Heyl and Zyxin but
not CtgfmRNA. This suggests that inhibition of TEAD an SRF co-factors,
YAP and MKL1 respectively, are involved in mediating the inhibition of
gene expression in response to increased nuclear actin. However, some
genes display a preference for either YAP-TEAD (e.g. Ctgf) or MKL-SRF
(e.g. Heyl). Expression of Ccn1 and Ctgf have been previously reported
to be required for efficient cell proliferation and migration [12,63]. We
therefore tested if inhibition of Heyl, Zyxin and Pai1 also contributes
towards the growth inhibitory and anti-migratory effects of intra-
nuclear actin. Transfection of cells with siRNA-targeting either Heyl,
Zyxin or Pai1 significantly reduced levels of the respective mRNAs
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(Supplement Fig. 9A, B and C) and significantly inhibited basal pro-
liferation (Supplement Fig. 9D) and migration rates (Supplement
Fig. 9E).
We tested the relative importance of MKL1-SRF and YAP/TAZ-TEAD
inhibition for the growth inhibitory effects of intranuclear actin.
Expression of NLS-ActinR62D significantly inhibited cell proliferation
(Fig. 8B), consistent with data presented in Fig. 2. Overexpression of
YAPS127A orTAZ5SA significantly increased basal proliferation rates and
completely abrogated the growth inhibitory effects of NLS-ActinR62D
(Fig. 8B). Expression MKL1Δ100 also significantly increased basal pro-
liferation but only partially reversed the inhibitory effects of NLS-Ac-
tinR62D (Fig. 8B). Expression of NLS-ActinR62D significantly inhibited
cell migration (Fig. 8C–E). Expression of either YAPS127A or TAZ5SA
strongly enhanced basal migration rates above that of controls and
completely reversed the inhibitory effects of NLS-ActinR62D, with mi-
gration rates in these cells remaining significantly higher than the basal
migration rate of Ad:Control cells (Fig. 8C and D). Expression of
MKL1Δ100 resulted in a small increase in basal migration rates and
rescued the inhibitory effects of NLS-ActinR62D to levels that were not
different from basal rates in Ad:Control infected cells (Fig. 8E). Taken
together, these data indicate that inhibition of TEAD is essential for the
growth inhibitory and anti-migratory effects of nuclear actin monomer.
Inhibition of SRF is also essential for the anti-migratory effects but only
partially required for the growth inhibitory effects of nuclear actin.
3. Discussion
In this study, we present evidence that nuclear actin plays a major
inhibitory role in regulating proliferation and migration of VSMCs. We
show that nuclear actin monomer levels rapidly increase in response to
multiple cAMP elevating stimuli, including activation of the adenosine
A2B and the prostacyclin receptors, which have widely documented
anti-mitogenic and anti-migratory effects in these cells
[23,35,36,53,56,64]. Increasing nuclear actin monomer levels via ex-
pression of NLS-ActinR62D, over expression of the actin importer, IPO9,
or silencing of the actin exporter, XPO6, all significantly inhibited
Fig. 7. Increased nuclear actin mediates the inhibitory effects of cAMP on SRF and TEAD activity and target gene expression.
VSMCs were transfected with SRE-LUC (A and C) or TEAD-LUC (B and D). Cells were infected with Ad:Control and either Ad:XPO6 (A and B) or Ad:mDIACT (C and
D). Reporter gene activity was quantified 24 h post infection (A-D). VSMC were infected with Ad:XPO6 (E) or Ad:mDIACT (F). Total RNA was extracted 24 h post
infection and analysed for SRF and TEAD-target genes using qRT-PCR (E and F).
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proliferation and migration. Moreover, preventing the cAMP mediated
increase in nuclear actin, either by enhancing its nuclear export with
XPO6 overexpression or by expressing nuclear localised constitutively-
active mDIA, which has previously been shown to promote nuclear
actin polymerisation [2], reversed the anti-mitogenic and anti-mi-
gratory effects of forskolin. Although forskolin can induce supraphy-
siological levels of intracellular cAMP in VSMCs [53], we demonstrate
that XPO6-mediated reduction of nuclear actin monomer levels also
reverses the anti-mitogenic and anti-migratory effects of BAY60-6583,
an adenosine A2B-receptor agonist that induces physiological levels of
cAMP in these cells [53]. Transcriptomic analysis of nuclear actin and
cAMP regulated genes detected a large overlap in genes repressed by
both signals, with repressed genes enriched in functions associated with
proliferation and migration. Importantly, transcription factor enrich-
ment analysis of the promoters of these genes identified enrichment of
binding elements for SRF and TEAD, suggesting a functional role for
these transcription factors in mediating the effects of intranuclear actin.
Consistent with this, we show that nuclear actin or cAMP inhibited SRF
and TEAD activity and inhibited expression of SRF and TEAD target
genes. Moreover, we show that the inhibitory effects of cAMP on SRF
Fig. 8. Active mutants of YAP, TAZ and MKL1 reverse the inhibitory effects of intranuclear actin on proliferation and migration
VSMCs were infected with Ad:Control, Ad:NLS-ActinR62D, Ad:YAP, Ad:TAZ or Ad:activeMKL1 as indicated. Total RNA was extracted 24 h later and analysed by RT-
PCR for the indicated target genes (A). One day post infection, cells were labelled with Edu for 4 h (B) or scratch wounded and migration quantified by Incucyte real
time migration assay (C–E).
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and TEAD-dependent gene expression are mediated via increased nu-
clear actin. Furthermore, inhibition of TEAD functionally underlies the
anti-mitotic and anti-migratory effects of nuclear actin since con-
stitutively active mutants of the TEAD co-factors YAP or TAZ com-
pletely rescued proliferation and migration in cAMP stimulated cells.
Rescuing SRF activity via expression of a constitutively active MKL1
only partially rescued proliferation, suggesting a dominant role for the
YAP/TAZ-TEAD pathway over MKL-SRF. The inhibitory effects of nu-
clear actin on proliferation and migration were mediated, at least in
part via inhibition of the SRF and TEAD-target genes Heyl, Zyxin and
Pai1. Taken together, these data demonstrate that intranuclear actin
mediates the inhibition of proliferation and migration by physiological
signals that activate cAMP signalling through inhibiting expression of
SRF and TEAD-target genes. Our data elucidates a new mechanism (see
Fig. 9) that links changes in intranuclear actin in response to physio-
logical signals to changes in cell proliferation and migration.
The presence of actin within the nucleus was originally reported in
the 1960s, although at the time this was not widely accepted, and its
function was unknown [8,31,61]. More recently, reports have con-
firmed the existence of actin in the nucleus and characterised its role in
the regulation of gene transcription, chromatin remodelling and cell
differentiation [32]. Although its existence within the nucleus is now
well established, very little is known about the physiological signals
that control nuclear actin levels. In epithelial cells, interaction with
extracellular matrix components such as Laminin-111 promotes nuclear
export of actin via increasing XPO6 [18]. In rat peritoneal mast cells,
ATP depletion is associated with an increase in nuclear actin levels,
suggesting that nuclear actin may be involved in cellular stress re-
sponses [45]. Increased levels of nuclear actin have also been detected
after phorbol ester stimulation of monocytic HL-60 cells, where it is
implicated in transcriptional regulation of macrophage differentiation
[66]. Here we demonstrate for the first time that physiological signals
that elevate cAMP promote a rapid increase in nuclear actin monomer
levels in VSMCs. We detected increases in nuclear actin monomer as
early as 1 h after stimulation with the adenosine A2B-receptor agonist
(BAY60-6583), which elevates intracellular cAMP [53]. This implies
that increases in nuclear actin levels is an early event preceding the
inhibitory effects of cAMP on proliferation and migration. Precisely
how cAMP signalling results in an increase in nuclear actin levels is
currently unknown. However, in VSMCs, cAMP signalling is known to
rapidly inhibit RhoGTPase activity and increase the F:G actin ratio
[5,53]. Changes in cytoplasmic actin monomer levels are known to
Fig. 9. Proposed model of nuclear actin
dependent regulation of YAP/TAZ-TEAD
and MKL-SRF-dependent gene expression
Activation of adenylyl cyclase in response
to Gs-coupled GPCR agonists increases in-
tracellular cAMP levels. Elevated cAMP in-
hibits RhoGTPase-dependent polymerisa-
tion of cytosolic actin, thus increasing the
availability of cytosolic actin monomer.
Actin monomer is transported into the nu-
cleus in association with importin-9 (IPO9).
Nuclear actin monomer levels are also
regulated by nuclear export, via exportin-6
(XPO6) or via their polymerisation, which
is promoted by nuclear formins such a
mDIA. Nuclear actin inhibits SRF activity,
at least in part via nuclear export of MKL1.
Nuclear actin inhibits YAP-TEAD activity,
independently of YAP nuclear export.
Nuclear actin-dependent inhibition of MKL-
SRF and YAP/TAZ-TEAD reduces expres-
sion of genes required for efficient pro-
liferation and migration.
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quickly lead to changes in nuclear actin monomer levels [20] and is a
rate limiting factor determining actin import [10]. Consistent with this,
we observed an increase in nuclear actin monomer levels following
latrunculin-B-mediated depolymerisation of cytoplasmic actin. There-
fore, a rapid increase in cytoplasmic actin monomer is likely, at least in
part, to underlie the increase in nuclear actin monomer in response to
cAMP. Increased levels of intranuclear actin monomer can promote the
formation of filaments of nuclear actin polymer [46]. However, our
data suggest that it is the increase in monomer, rather than polymer,
that is responsible for the anti-mitogenic and anti-migratory effects of
cAMP. For example, expression of mDIA-CT reduces nuclear actin
monomer levels by enhancing polymerisation within the nucleus and
increases cell proliferation and migration. In contrast, elevated cAMP
increases nuclear actin monomer levels but inhibits proliferation and
migration.
The anti-mitogenic and anti-migratory properties of cAMP are well
characterised [7,24,27,53,54] but the underlying mechanisms are not
fully understood. Previous research has implicated inhibition of Rho
GTPases and impaired actin polymerisation, which is associated with
the acquisition of a characteristic stellate morphology, characterised by
reduced cell spreading and loss of F-actin stress fibres [24]. These ef-
fects on the cytoplasmic actin cytoskeleton were assumed to be re-
sponsible for the anti-mitogenic and anti-migratory effects of cAMP
since expression of constitutively active Rho GTPases could reverse the
effects of cAMP on cell spreading, cytoplasmic actin polymerisation and
ultimately proliferation and migration [5]. However, we now demon-
strate that cAMP elevating stimuli also increase levels of actin monomer
within the nucleus. It is noteworthy that one of the earliest reports of
actin being present within the nucleus found that contact inhibition of
fibroblast growth resulted in “a significant increase in the intranuclear
concentration of a protein which comigrates with Physarum nuclear actin”
[38], although the functional significance of this was unknown at the
time. Our new data demonstrates that increased levels of nuclear actin
monomer underlie the anti-mitogenic and anti-migratory effects of
cAMP in VSMCs.
The anti-mitogenic effects of cAMP are known to be cell-type spe-
cific, which may in part reflect divergent effects of cAMP on cyto-
plasmic actin reorganisation in these cells [53]. For example, cAMP
induces rapid loss of actin stress fibres and actin depolymerisation in
some cell types, including fibroblasts [15], mesenchymal stem cells
[69] and VSMC [5,34] [12], while other cell types, such as ECs [53],
cAMP promotes actin polymerisation and formation of cortical actin
stress fibres. Consistent with this, we observed opposing effects of cAMP
on intranuclear actin monomer levels in VSMCs compared to ECs, being
increased in VSMCs and decreased in ECs. This may simply mirror
changes in cytoplasmic actin monomer availability that occurs in these
cells after cAMP stimulation. Nevertheless, the function of intranuclear
actin in these cells also appears to be cell-type specific. Over expression
of NLS-ActinR62D in ECs resulted in a small increase in proliferation and
did not affect migration rate, in contrast to its inhibitory effects in
VSMCs. Interestingly, nuclear actin appears to play a pro-mitogenic
function in epithelial cells, where quiescence induced by culture on a
laminin-111 is associated with reduced levels of nuclear actin and re-
duced gene transcription. In these cells, expression of NLS-ActinR62D
rescues their proliferation and restores transcription [18,57].
Our transcriptomic analysis detected both increased and decreased
expression of many genes in response to elevated levels of nuclear actin,
indicating that nuclear actin modulates specific gene regulatory me-
chanisms instead of globally effecting transcription per se. Our analysis
of nuclear actin repressed genes detected enrichment of genes asso-
ciated with proliferation and migration. Importantly, we detected a
substantial overlap between genes repressed by elevated cAMP or nu-
clear actin, consistent with a model where cAMP represses genes re-
quired for proliferation by elevating intranuclear actin levels.
Transcription factor enrichment analysis and GSEA of these repressed
genes identified SRF and TEAD dependent gene signatures, indicating
inhibition of SRF and TEAD underlies many of the transcriptional
changes we detected. Inhibition of SRF and TEAD was confirmed by
reporter gene analysis. Inhibition of SRF activity is consistent with data
obtained in NIH 3T3 fibroblasts, where nuclear actin regulates MKL
nuclear export and activity of MKL-SRF complexes [61]. An SRF gene
signature is consistent with our previous demonstration that cAMP re-
presses SRF activity in VSMCs [53], which also occurs, at least in part,
via enhanced nuclear export of MKL1 and our observation reported
here that nuclear actin also prevents accumulation of MKL1 in the
nucleus and inhibits SRF activity. Interestingly, expression of con-
stitutively active actin independent MKL1 (ΔN100-MKL), lacking the
actin-binding RPEL domains, only partially reversed the inhibitory ef-
fects of nuclear actin on proliferation, implicating additional mechan-
isms. Nevertheless, ΔN100-MKL completely reversed the inhibition of
migration by NLS-ActinR62D, suggesting a more important role for MKL1
in the regulation of migration compared to proliferation. This is con-
sistent with previously reported MKL1-linked gene signatures being
associated with cell motility and cytoskeleton dynamics [17]. On the
other hand, very little is known about the role of nuclear actin in the
regulation of TEAD activity. Here we demonstrated inhibition of TEAD
reporter activity and target gene expression by nuclear actin. Im-
portantly, we found that active mutants of YAP or TAZ completely re-
versed the anti-mitogenic effects of nuclear actin, implying a major role
for the YAP/TAZ-TEAD axis compared to the MKL1-SRF axis in med-
iating the growth inhibitory effects of intranuclear actin. These data
highlight for the first time that inhibition of YAP/TAZ-TEAD is an im-
portant mechanism mediating the biological effects of nuclear actin.
Although our data clearly demonstrates inhibition of TEAD activity by
nuclear actin, the underlying mechanisms are unknown. Inhibition of
TEAD activity was not associated with nuclear export of YAP or changes
in YAP phosphorylation status, in contrast to cAMP or disruption of the
cytoplasmic actin cytoskeleton, which did induce YAP export and
phosphorylation [36]. This suggests that the nuclear YAP/TAZ-TEAD
complex is susceptible to regulation by nuclear actin via a mechanism
that is independent of changes in co-factor nuclear export of phos-
phorylation (See Fig. 9). This is model is consistent with recent data
demonstrating that YAP constrained to the nucleus by XPO1 silencing
remains sensitive to actomyosin disruption [16]. Recent reports have
described reciprocal regulation between MKL-SRF and YAP-TEAD
pathways [19] and enhancement of YAP-TEAD activity via direct in-
teractions and formation of an MKL1-YAP-TEAD complex [33], raising
the possibility that inhibition of TEAD activity by nuclear actin may
occur as a result of actin sequestration of MKL1. However, our data
does not support this model, instead pointing to an MKL1-independent
repression of TEAD activity. Given the well characterised role of TEAD
transcription factors in the regulation of cell proliferation and their
dysregulation in hyper-proliferative pathologies and cancer, it is im-
portant that future research focusses on characterising these mechan-
isms further.
Although there has been great interest in the molecular functions of
intranuclear actin in recent years, relatively little is known about the
importance of nuclear actin dynamics in the regulation of cell beha-
viour. Here we describe a novel role for nuclear actin monomer in the
regulation of cell proliferation and migration of vascular smooth muscle
cells. We show for the first time that elevated nuclear actin levels in-
hibit cell proliferation and migration of these cells. We show that this is
mediated, at least in part, via inhibition of the Hippo-pathway target
transcription factor complex YAP/TAZ-TEAD. We also show that this
novel mechanisms accounts for the anti-mitogenic and anti-migratory
effects of physiological signals that elevate cAMP.
4. Materials and methods
4.1. Reagents
All chemicals were obtained from Sigma unless otherwise stated.
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Antibodies to YAP and Lamin A/C (#4777) were from Cell Signalling
Technologies. Antibody to GAPDH (MAB374) was from Millipore.
Antibodies to YAP (#140745), YAP phospho-serine-127 (#4911), YAP
phospho-serine-397 (#13619) and FLAG-tag (#14793) were from Cell
Signalling Technologies. Antibody to XPO6 (ab72333) was from
Abcam. Silencer Select siRNA targeting rat XPO6 (s147550) and non-
targeting negative control (#4404020) were from Thermo Fisher
Scientific.
4.2. Smooth muscle and endothelial cell culture
Male Sprague Dawley rats were killed by cervical dislocation in
accordance with schedule 1 of the U.K. Animals (Scientific Procedures)
Act 1986 and Directive 2010/63/EU of the European Parliament and
with the approval of the University of Bristol. Methods used to culture
VSMCs and ECs are described in detail in the Supplement. Human aortic
VSMCs (HuVSMCs) and human umbilical endothelial cells (HUVC) at
passage 2–8 were purchased from Promocell. All experiments were
replicated for the number of time shown in the text and figures using
different batches of cells that were prepared from different animals/
donors. Cultures of rat aortic VSMCs (RaVSMCs) were prepared as
previously described [22] and cultured in Dulbecco's Modified Eagle's
Medium (DMEM) supplemented with 10% foetal bovine serum, 100 U/
ml penicillin/streptomycin and 2.5 mM L-glutamine. Human VSMC
were cultured in human smooth muscle cell growth medium 2 (Pro-
mocell), supplemented with the supplement pack (Promocell), 100 U/
ml penicillin/streptomycin and 2.5 mM L-glutamine. HUVEC were
cultured in Endothelial Cell Growth Medium 2 supplemented with the
supplied supplement pack (Promocell), 100 U/ml penicillin/strepto-
mycin and 2.5 mM L-glutamine.
4.3. Real-time scratch wound migration assays
Real-time analysis of migration was performed using an IncuCyte®
ZOOM live cell imaging system (Essen BioScience) according to the
manufacturer's instructions. Briefly, cells were seeded (2 × 104 cells/
well for RaVSMCs, 1 × 104 cells/well for HuVSMCs and 2 × 104 cells/
well for HUVECs) into ImageLock-96 well plates. Wells were scratched
using a WoundMaker® tool and phase contrast images of cell migration
into the wounded area acquired hourly for 24 h. Relative wound con-
fluence was calculated using the Cell Migration Image analysis module
of the IncuCyte ® ZOOM software.
4.4. Quantitative RT-PCR and western blotting
Quantification of mRNA and protein levels was performed by RT-
qPCR and western blotting respectively, as described previously [24].
Total RNA was extracted using Ambion Pure-Link kits (Thermo Fisher)
and was reverse transcribed using QuantiNova RT kit (Qiagen) and
random primers. Quantitative PCR was performed using Roche SYBR
Green using a Qiagen Roto-Gene Q PCR machine (20’@95 °C;20’@
62 °C;20’@72 °C). Primers sequences are described in Supplement
Table 1. Data were normalised to total amount of RNA. Western blots
were performed using a Mini-Protean II system. Proteins were trans-
ferred to PVDF membrane using a semi-dry Turbo blotter system (Bio-
Rad) and detected using ECL and a digital ChemiDoc imaging system
(Bio-Rad). Phos-tag gels were prepared containing 100 μM Phos-tag
acrylamide and 20 μM MnCl2 according to the manufacturer's instruc-
tions (Alpha Laboratories).
4.5. Plasmids, siRNA and adenoviral vectors
Replication deficient adenoviral vectors were generated by cloning
cDNAs into the multiple cloning site of the pDC515 adenovirus shuttle
vector (Microbix) as previously described [36]. Adenovirus expressing
FLAG-tagged actin containing a nuclear localisation signal and an R62D
mutation to prevent polymerisation was generated by cloning FLAG-
NLS-β-ACTIN-R62D cDNA into the EcoR1 and Nhe1 sites of plasmid
pDC515 followed by homologous recombination with adenovirus
genome vector pBHG-frt in HEK293 cells. Adenovirus (Ad:mDIA-CT)
expressing constitutively active nuclear mouse mDIA was made by
subcloning the F1F2+C fragment of mDIA1 from pEF-mDIA-F1F2+C
plasmid (a generous gift from John Copeland and described previously
[2]) into the BamH1 and Sal1 sites of pDC515. Adenovirus expressing
mouse Importin-9 (IPO9) was generated by PCR amplifying the IPO9
cDNA from MGC cDNA clone BC098508 and cloning into the Nhe1 and
Sal1 sites of pDC515. Adenovirus expressing human Exportin-6 (XPO6)
was amplified by PCR and cloned into the Nhe1 and BamH1 sites of
plasmid pDC515. Plasmid TEAD-LUC expressing firefly luciferase under
the control of a synthetic promoter containing eight copies of a con-
sensus TEAD binding element was obtained from Addgene (#34615)
and has been described previously [36] [13]. Plasmid SRE-LUC ex-
pressing firefly luciferase under the control of a synthetic promoter
containing five SRE elements was purchased from Agilent. All Silencer
Select siRNAs were purchased from Invitrogen Life Technologies.
4.6. Transient transfection and reporter gene assays
TEAD and SRF reporter gene activity was determined by quantifying
the cellular luciferase reporter activity in cells transfected with TEAD-
LUC or SRE-LUC. Plasmid transfection was performed by electropora-
tion of 1 × 106 cells with 5 μg of plasmid DNA using an Amaxa
Nucleofector-1.5 (program A-033). For gene silencing, cells were
transfected with 100 pmoles of Silencer Select siRNA (Life
Technologies). At the indicated times post transfections, cell lysates
were prepared in ice cold Cell Culture Lysis (CLB) buffer (Promega) and
assayed for firefly luciferase activity using the luciferase assay system
(Promega) and a Glomax Discover luminometer (Promega) according to
the manufacturer's instructions.
4.7. Quantification of intranuclear actin using DNAse1 staining
Levels of intranuclear actin were detected by staining fixed cells
with a DNAse1-Alexa Fluor-594 conjugate, essentially as previously
described [57] [37]. Cells were fixed for 10 min at room temperature in
4% methanol-free formaldehyde. Cells were permeabilised with 0.1%
Triton-X-100 and blocked in 5% bovine serum albumin for 20 min at
room temperature followed by incubation with 9 μg/ml of DNAse1-
Alexa Fluor-594 for 20 min at room temperature. Cells were washes in
PBS and the nuclei counter stained with Hoechst 33342. Cells were
imaged using a Leica confocal microscope. The nuclear DNAse1-Alexa
Fluor-594 fluorescent signal was quantified in Z-slice images passing
through the nuclei using an automated ImageJ script.
4.8. RNA-seq and bioinformatics
Total RNA was extracted from VSMC and EC using the PureLink
RNA Mini Kit (Ambion) as per manufacturer's instructions. For RNA-
sequencing, an additional on column DNase1 treatment step was in-
cluded to assure highly pure RNA without genomic DNA contamina-
tion. RNA was then quantified using Nanodrop spectrophotometer
technology (LabTech; model number: ND-1000). RNA concentration
was obtained by measuring absorbance at 260 nm and 260/230 and
260/280 ratios determined the extent of ethanol and protein con-
tamination, respectively. Only samples with sufficient purity were used
for subsequent experiments. RNA-seq libraries were prepared using
Illumina TruSeq stranded total RNA sample preparation kits including a
ribodepletion step. Libraries were sequenced (100 bp paired end reads)
using an Illumina HiSeq next generation sequencer. Raw reads were
assessed for quality using the FastQC tool and trimmed as necessary
using Cutadapt (a Python Command Line Tool, Dortmund, Germany).
Trimmed reads were then aligned using HISAT2 and assembled using
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StringTie (http://ccb.jhu.edu/software.shtml). Raw count data was
produced from the aligned reads using featureCounts (an R package,
http://bioinf.wehi.edu.au/featureCounts/), and then differential ex-
pression analysis using edgeR (Empirical Analysis of Digital Gene
Expression Data in R, https://bioconductor.org/packages/release/bioc/
html/edgeR.html). Enrichment of transcription factor binding elements
in gene promoters was performed using the online oPOSSUMv3.0 tool
(http://opossum.cisreg.ca/oPOSSUM3/) [60]. Consensus binding ele-
ments for TEAD (TEAD1:MA0090.1; TEAD2: MA1121.2;-
TEAD3:MA0808.1; TEAD4:MA0809.1) in the 10kbp upstream of the
transcription start site of regulated genes were identified using FIMO
(http://meme-suite.org/tools/fimo) [3]. Gene ontology enrichment
analysis was performed using the DAVID bioinformatics resource
(https://david.ncifcrf.gov/) [9]. Gene Set Enrichment analysis was
performed using R packages clusterProfiler [68] and fgsea [51] with
1000 permutations on pre-ranked gene lists generated using R package
DESeq2 [41]. As necessary human homologues for rat gene IDs were
obtained using the BiomaRt R package [14]. Gene sets were obtained
from the Broad Institute Molecular Signatures Database [59] [39]:
Hallmark [40] and C3, Transcription Factor Targets [65]; Zhao et al.
supplementary Table 2, “Common Genes” [70]; Ensault et al., supple-
mentary Table 5, (Bind SRF, serum-inducible, responsive to SRF-linked
signals) [17]. TEAD ChIP (ENCODE) lists were generated by over-
lapping peaks for Tead4 ChIP from cell lines HepG2, K562, A549 and
MCF7. SRF ChIP (ENCODE) lists were generated by overlapping peaks
for SRF ChIP from cell lines GM12878, HepG2, K562, MCF7 and Hct11.
Peaks were assigned to genes using R package ChIPpeakAnno [71].
4.9. Statistical analysis
After testing for Gaussian distribution, statistical analysis was per-
formed using two-way ANOVA, one-way ANOVA with Student-
Newman-Keuls post-test or where appropriate a paired student's t-test,
as indicated. *Indicates p < 0.05, **indicates p < 0.01, ***indicates
p < 0.001.
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